Literature DB >> 15560957

A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients.

A Fresán1, C De la Fuente-Sandoval, C Loyzaga, M García-Anaya, N Meyenberg, H Nicolini, R Apiquian.   

Abstract

UNLABELLED: The heterogeneity of schizophrenic symptomatology is well documented. The positive-negative distinction is limited to cover the entire spectrum of schizophrenic psychopathology in order to describe the various clinical aspects of the disorder.
METHOD: We recruited 150 schizophrenic patients between May 2002 and September 2003. Diagnoses were based on a structured clinical interview. The Positive and Negative Syndrome Scale (PANSS) was used to evaluate general psychopathology and symptom severity. For the concurrent validity of the pentagonal model of the PANSS, the BPRS, the CDSS, the OAS and the MMSE were used.
RESULTS: The forced five-factor principal-component analysis explained 53.4% of the total variance. There were significant correlations between the clinical rating scales and the five components of the PANSS. DISCUSSION: Our data support a pentagonal model underlying the multidimensional schizophrenic symptomatology as assessed by the PANSS. The five-factor structure of the PANSS in Mexican schizophrenic patients enables further elucidation of the various clinical aspects of schizophrenia.

Entities:  

Mesh:

Year:  2005        PMID: 15560957     DOI: 10.1016/j.schres.2004.03.021

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  18 in total

1.  The relationships between patients' and caregivers' beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries.

Authors:  Alejandra Caqueo-Urízar; Laurent Boyer; Karine Baumstarck; Stephen E Gilman
Journal:  Psychiatry Res       Date:  2015-06-29       Impact factor: 3.222

2.  Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia.

Authors:  R S Wallwork; R Fortgang; R Hashimoto; D R Weinberger; D Dickinson
Journal:  Schizophr Res       Date:  2012-02-21       Impact factor: 4.939

3.  Latent Profiles of Premorbid Adjustment in Schizophrenia and Their Correlation with Measures of Recovery.

Authors:  Alejandra Caqueo-Urízar; Felipe Ponce-Correa; Carla Semir-González; Alfonso Urzúa
Journal:  J Clin Med       Date:  2022-07-02       Impact factor: 4.964

4.  History of religious delusions and psychosocial functioning among Mexican patients with paranoid schizophrenia.

Authors:  Rebeca Robles-García; Sonia López-Luna; Francisco Páez; Raúl Escamilla; Beatriz Camarena; Ana Fresán
Journal:  J Relig Health       Date:  2014-12

5.  Needs of Patients with Schizophrenia Among an Ethnic Minority Group in Latin America.

Authors:  Alejandra Caqueo-Urízar; Laurent Boyer; Stephen E Gilman
Journal:  J Immigr Minor Health       Date:  2017-06

6.  Early Response in Adolescents with Schizophrenia is not Associated with Remission at Six Months.

Authors:  Sadot Arceo; Rosa Elena Ulloa
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2019-08-01

7.  Perceived discrimination is associated with severity of positive and depression/anxiety symptoms in immigrants with psychosis: a cross-sectional study.

Authors:  Akiah O Berg; Ingrid Melle; Jan Ivar Rossberg; Kristin Lie Romm; Sara Larsson; Trine V Lagerberg; Ole A Andreassen; Edvard Hauff
Journal:  BMC Psychiatry       Date:  2011-05-06       Impact factor: 3.630

8.  Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS).

Authors:  Anzalee Khan; Charles Lewis; Jean-Pierre Lindenmayer
Journal:  BMC Psychiatry       Date:  2011-11-16       Impact factor: 3.630

9.  The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.

Authors:  Miguel Herrera-Estrella; Rogelio Apiquian; Ana Fresan; Isabel Sanchez-Torres
Journal:  BMC Psychiatry       Date:  2005-05-03       Impact factor: 3.630

10.  Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome.

Authors:  Marcelo Valencia; Ana Fresán; Yoram Barak; Francisco Juárez; Raul Escamilla; Ricardo Saracco
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.